163 related articles for article (PubMed ID: 20869097)
1. Down-regulation of the antigen processing machinery is linked to a loss of inflammatory response in colorectal cancer.
Kasajima A; Sers C; Sasano H; Jöhrens K; Stenzinger A; Noske A; Buckendahl AC; Darb-Esfahani S; Müller BM; Budczies J; Lehman A; Dietel M; Denkert C; Weichert W
Hum Pathol; 2010 Dec; 41(12):1758-69. PubMed ID: 20869097
[TBL] [Abstract][Full Text] [Related]
2. Expression of transporters associated with antigen processing and human leucocyte antigen class I in malignant melanoma and its association with prognostic factors.
Tao J; Li Y; Liu YQ; Li L; Liu J; Shen X; Shen GX; Tu YT
Br J Dermatol; 2008 Jan; 158(1):88-94. PubMed ID: 17999701
[TBL] [Abstract][Full Text] [Related]
3. HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.
Vitale M; Rezzani R; Rodella L; Zauli G; Grigolato P; Cadei M; Hicklin DJ; Ferrone S
Cancer Res; 1998 Feb; 58(4):737-42. PubMed ID: 9485029
[TBL] [Abstract][Full Text] [Related]
4. Restoration of the expression of transports associated with antigen processing in human malignant melanoma increases tumor-specific immunity.
Tao J; Li Y; Liu YQ; Wang L; Yang J; Dong J; Wu Y; Shen GX; Tu YT
J Invest Dermatol; 2008 Aug; 128(8):1991-6. PubMed ID: 18385764
[TBL] [Abstract][Full Text] [Related]
5. MHC class I antigen processing pathway defects, ras mutations and disease stage in colorectal carcinoma.
Atkins D; Breuckmann A; Schmahl GE; Binner P; Ferrone S; Krummenauer F; Störkel S; Seliger B
Int J Cancer; 2004 Mar; 109(2):265-73. PubMed ID: 14750179
[TBL] [Abstract][Full Text] [Related]
6. Natural killer cells infiltrating colorectal cancer and MHC class I expression.
Sandel MH; Speetjens FM; Menon AG; Albertsson PA; Basse PH; Hokland M; Nagelkerke JF; Tollenaar RA; van de Velde CJ; Kuppen PJ
Mol Immunol; 2005 Feb; 42(4):541-6. PubMed ID: 15607811
[TBL] [Abstract][Full Text] [Related]
7. HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinoma.
Han LY; Fletcher MS; Urbauer DL; Mueller P; Landen CN; Kamat AA; Lin YG; Merritt WM; Spannuth WA; Deavers MT; De Geest K; Gershenson DM; Lutgendorf SK; Ferrone S; Sood AK
Clin Cancer Res; 2008 Jun; 14(11):3372-9. PubMed ID: 18519766
[TBL] [Abstract][Full Text] [Related]
8. Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7/TAP2 downregulation in MSI-negative tumors.
Cabrera CM; Jiménez P; Cabrera T; Esparza C; Ruiz-Cabello F; Garrido F
Tissue Antigens; 2003 Mar; 61(3):211-9. PubMed ID: 12694570
[TBL] [Abstract][Full Text] [Related]
9. CD20+ tumor-infiltrating lymphocytes have an atypical CD27- memory phenotype and together with CD8+ T cells promote favorable prognosis in ovarian cancer.
Nielsen JS; Sahota RA; Milne K; Kost SE; Nesslinger NJ; Watson PH; Nelson BH
Clin Cancer Res; 2012 Jun; 18(12):3281-92. PubMed ID: 22553348
[TBL] [Abstract][Full Text] [Related]
10. Loss of major histocompatibility complex-encoded transporter associated with antigen presentation (TAP) in colorectal cancer.
Kaklamanis L; Townsend A; Doussis-Anagnostopoulou IA; Mortensen N; Harris AL; Gatter KC
Am J Pathol; 1994 Sep; 145(3):505-9. PubMed ID: 8080034
[TBL] [Abstract][Full Text] [Related]
11. Functional down-regulation of beta1 and beta2 integrins of lamina propria lymphocytes (LPL) and tumor-infiltrating lymphocytes (TIL) in colorectal cancer patients.
Kitayama J; Tuno N; Nakayama H; Shibata Y; Muto T; Nagawa H
Ann Surg Oncol; 1999; 6(5):500-6. PubMed ID: 10458690
[TBL] [Abstract][Full Text] [Related]
12. Characterization of human lymphocyte antigen class I antigen-processing machinery defects in renal cell carcinoma lesions with special emphasis on transporter-associated with antigen-processing down-regulation.
Seliger B; Atkins D; Bock M; Ritz U; Ferrone S; Huber C; Störkel S
Clin Cancer Res; 2003 May; 9(5):1721-7. PubMed ID: 12738726
[TBL] [Abstract][Full Text] [Related]
13. Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.
Mehta AM; Jordanova ES; Kenter GG; Ferrone S; Fleuren GJ
Cancer Immunol Immunother; 2008 Feb; 57(2):197-206. PubMed ID: 17622526
[TBL] [Abstract][Full Text] [Related]
14. Tumor infiltrating T lymphocytes in colorectal cancer: Tumor-selective activation and cytotoxic activity in situ.
Koch M; Beckhove P; Op den Winkel J; Autenrieth D; Wagner P; Nummer D; Specht S; Antolovic D; Galindo L; Schmitz-Winnenthal FH; Schirrmacher V; Büchler MW; Weitz J
Ann Surg; 2006 Dec; 244(6):986-92; discussion 992-3. PubMed ID: 17122624
[TBL] [Abstract][Full Text] [Related]
15. Development and characterization of rabbit antisera to human MHC-linked transporters associated with antigen processing.
Hicklin DJ; Kageshita T; Ferrone S
Tissue Antigens; 1996 Jul; 48(1):38-46. PubMed ID: 8864173
[TBL] [Abstract][Full Text] [Related]
16. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
17. Expression of antigen processing and presenting molecules in brain metastasis of breast cancer.
Liu Y; Komohara Y; Domenick N; Ohno M; Ikeura M; Hamilton RL; Horbinski C; Wang X; Ferrone S; Okada H
Cancer Immunol Immunother; 2012 Jun; 61(6):789-801. PubMed ID: 22065046
[TBL] [Abstract][Full Text] [Related]
18. Correlation between expression of major histocompatibility complex class I and that of antigen presenting machineries in carcinoma cell lines of the pancreas, biliary tract and colon.
Imanishi T; Kamigaki T; Nakamura T; Hayashi S; Yasuda T; Kawasaki K; Takase S; Ajiki T; Kuroda Y
Kobe J Med Sci; 2006; 52(3-4):85-95. PubMed ID: 16855371
[TBL] [Abstract][Full Text] [Related]
19. TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis.
Kamarashev J; Ferrone S; Seifert B; Böni R; Nestle FO; Burg G; Dummer R
Int J Cancer; 2001 Jan; 95(1):23-8. PubMed ID: 11241306
[TBL] [Abstract][Full Text] [Related]
20. Pseudomonas aeruginosa Cif protein enhances the ubiquitination and proteasomal degradation of the transporter associated with antigen processing (TAP) and reduces major histocompatibility complex (MHC) class I antigen presentation.
Bomberger JM; Ely KH; Bangia N; Ye S; Green KA; Green WR; Enelow RI; Stanton BA
J Biol Chem; 2014 Jan; 289(1):152-62. PubMed ID: 24247241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
